Last reviewed · How we verify

NCT04829513

Exercise and Two Different Kinesiotape Applications in Patients With Sacroiliac Joint Dysfunction

Completed NA Last updated 21 August 2024
What this trial tests

NA trial testing Home Exercise in Sacroiliac Joint Dysfunction in 99 participants. Completed in 20 July 2024.

Timeline
1 December 2016
Primary endpoint
20 July 2024
20 July 2024

Quick facts

Lead sponsorUfuk University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment99
Start date1 December 2016
Primary completion20 July 2024
Estimated completion20 July 2024
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Ufuk University

Who can join

Adults 18 to 65, any sex, with Sacroiliac Joint Dysfunction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is a randomized controlled study. 99 patients between the ages of 18-65 who were diagnosed with sacroiliac joint dysfunction will be included in the study.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Exercise and two different kinesio taping techniques in patients with sacroiliac joint dysfunction: A randomized controlled trial.
    Sonel Tur B, Karacif D, Ay S, Gökmen D, et al · · 2025 · PMID 41256783 · DOI 10.5606/tftrd.2024.15545

Verify or expand the search:

Other trials of Home Exercise

Trials testing the same drug.

Other recruiting trials for Sacroiliac Joint Dysfunction

Currently open trials in the same condition.

Other Ufuk University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04829513.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing